About: Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Sector: Healthcare
Industry: Biotechnology
Latest price: $378.30 (-4.65%)
MDGL NASDAQ Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals Inc share price
Atividade de preço de MDGL
Último preço
$ 378,300
Variação (24h)
-18,44 USD (4,65%)
Volume
280.78K
Volume (média 4 sem.)
-
Abertura
$ 396,21
Variação do dia
$ 377,91 - $ 399,43
Fechamento anterior
$ 396,74
Último negócio
20 Nov, 8:59 pm GMT+0
Atrasado
20 Nov, 8:59 pm GMT+0
MDGL price performance
Atrasado
20 Nov, 8:59 pm GMT+0
MDGL details
quote.marketSignals